Ovid Therapeutics' IPO

Ovid Therapeutics raised a round of funding on May 05, 2017. Investors include Public.

Ovid Therapeutics (NASDAQ: OVID) is a New York-based biopharmaceutical company using its BoldMedicine approach to develop therapies that transform the lives of patients with rare neurological diseases…

Articles about Ovid Therapeutics' IPO: